View Author
patient schizophrenia control study group psychiatry symptom treatment effect disorder antipsychotic subject level medication picture response monocyte score signi table expression factor research sample flammatory system control subjects analysis psychosi risperidone rating emotion result scale cannabi university signi ficantly recognition model state cohort adherence olanzapine cannabis use baseline difference <0.01 antipsychotic medication sibling disease analyte ficant control group serum haloperidol journal cortisol participant t cells depressive heart correlation ficantly measure depressive symptoms signi ficant outcome bipolar netherland blood department scz patients signature interaction performance medicated duration figure transcription pu .1
10 Most Recent Publications
|
Depressive symptoms are associated with (sub)clinical psychotic symptoms in patients with non-affective psychotic disorder, siblings and healthy controls
(Article)
Klaassen, R.M.C. Heins, M. Luteijn, L.B. Gaag, M. van der Beveren, N.J.M. van |
2013-04-01
|
|
Cardiac responses during picture viewing in young male patients with schizophrenia
(Article)
Hempel, R.J. Thayer, J.F. Röder, C.H. Steenis, H.G. van Beveren, N.J.M. van Tulen, J.H.M. |
2012-12-03
|
|
Psychometric evaluation of the subjective well-being under neuroleptic treatment scale (SWN) in patients with schizophrenia, their relatives and controls
(Article)
Vothknecht, S. Meijer, C. Zwinderman, A.H. Kikkert, M.A. Dekker, J. Beveren, N.J.M. van Schoevers, R. Haan, L. de |
2012-09-28
|
|
AKT1 Moderation of Cannabis-Induced Cognitive Alterations in Psychotic Disorder
(Article)
Winkel, R. van Beveren, N.J.M. van Krabbendam, L. Myin-Germeys, I. Simons, C.P.M. Kahn, R.S. Linszen, D. Os, J. van Wiersma, D. Bruggeman, R. Cahn, W. Haan, L. de |
2011-07-20
|
|
An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces
(Article)
Drexhage, R.C. Hoogenboezem, T.A. Cohen, D. Versnel, M.A. Nolen, W.A. Beveren, N.J.M. van Drexhage, H.A. |
2011-07-01
|
|
Identification of a biological signature for schizophrenia in serum
(Article)
Schwarz, E. Guest, P.C. Ohrmann, P. Suslow, T. McAllister, G. Spain, M. Barnes, A. Beveren, N.J.M. van Baron-Cohen, S. Steiner, J. Torrey, F.E. Yolken, R.H. Rahmoune, H. Bahn, S. Harris, L.W. Wang, L. Leweke, F.M. Rothermundt, M. Bogerts, B. Koethe, D. Kranaster, L. |
2011-04-12
|
|
Op maat gesneden interventie bevordert therapietrouw bij psychotische patiënten: een RCT*
(Article)
Staring, A.B.P. Gaag, M. van der Koopmans, G.T. Selten, J.P. Beveren, N.J.M. van Loonen, A.J.M. Mulder, C.L. |
2011-03-10
|
|
TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors
(Article)
Weigelt, K. Carvalho, L.A. Drexhage, R.C. Wijkhuijs, A.J.M. Wit, H.J. de Beveren, N.J.M. van Birkenhäger, T.K. Bergink, V. Drexhage, H.A. |
2011-03-01
|
|
Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia
(Article)
Guest, P.C. Schwarz, E. Rahmoune, H. Bahn, S. Krishnamurthy, D. Harris, L.W. Leweke, F.M. Rothermundt, M. Beveren, N.J.M. van Spain, M. Barnes, A. Steiner, J. |
2011-01-20
|
|
Treatment adherence therapy in people with psychotic disorders: randomised controlled trial
(Article)
Staring, A.B.P. Gaag, M. van der Koopmans, G.T. Selten, J.P. Beveren, N.J.M. van Hengeveld, M.W. Loonen, A.J.M. Mulder, C.L. |
2010-12-01
|
